Free Republic

The Ebola outbreak has taken more than 5,000 lives in West Africa and infected more than 14,000 individuals in just eight months. During the outbreak crisis, many organizations are clamoring to produce the first cure for the disease. However, an expert from the World Health Organization says that the key to surviving the fatal disease is as simple as drinking water. Dr. Simon Mardel, a veteran relief physician who is consulting on the crisis in West Africa says hydration is most effective way to fight the deadly disease until more extensive and potent treatment options like medicines and vaccines are...

Man who died from Ebola endured treatment delaysOMAHA, Neb. (AP) — A surgeon who contracted Ebola in his native Sierra Leone did not receive aggressive treatment until nearly two weeks after he first started showing symptoms — a delay that doctors said probably made it impossible for anyone to save his life

West Africa is currently experiencing the largest outbreak of Ebola virus disease (EVD) in history. Two patients with EVD were transferred from Liberia to our hospital in the United States for ongoing care. Malaria had also been diagnosed in one patient, who was treated for it early in the course of EVD. The two patients had substantial intravascular volume depletion and marked electrolyte abnormalities. We undertook aggressive supportive measures of hydration (typically, 3 to 5 liters of intravenous fluids per day early in the course of care) and electrolyte correction. As the patients' condition improved clinically, there was a concomitant...

We have technology to potentially control Ebola and other viral outbreaks today. But the federal bureaucracy refuses to catch up with 21st-century science. For example, diagnostic startup Nanobiosym has an iPhone-sized device that can accurately detect Ebola and other infectious diseases in less than an hour. Two other companies, Synthetic Genomics and Novartis, have the capacity to create synthetic vaccine viruses for influenza and other infectious diseases in only four days. Both firms can also share data about outbreaks instantaneously and make real-time, geographically specific diagnosis and vaccine production possible. These companies could start producing Ebola vaccine/treatments tomorrow — except...

While most of the recent coverage of the ongoing Ebola outbreak has focused on rising death tolls and a few infected US citizens, other segments of the population have passed mostly unnoticed from the harsh glare of the media spotlight: survivors, and those who are seemingly immune to Ebola.People who survive Ebola can lead normal lives post-recovery, though occasionally they can suffer inflammatory conditions of the joints afterward, according to CBS. Recovery times can vary, and so can the amount of time it takes for the virus to clear out of the system.The World Health Organization found that the virus...

Is Obama Planning to Flood the System With Foreign Ebola Patients? As if the last few weeks have not been crazy enough. First we learned that a Liberian national who landed in Dallas had tested positive for Ebola. We then witnessed a comedy of errors as workers and authorities tried to deal with "patient zero." Shortly after we learned that not just one, but two nurses who treated Thomas Duncan had also been stricken with Ebola. Now we are hearing from Judicial Watch that Barack Obama is planning to bring more Ebola patients to America… on purpose. Maybe that is...

Here is my plan for treating the Ebola patients IN PLACE IN THEIR REGION - NOT IN AMERICA - costly yes, but it would be effective, It keeps Ebola patients out of America, It creates a Very Positive Image for America and Americans and the Western World, It has a good chance of working, It would be done in the American style of yesteryear - Going Big and taking care of the problem. You can laugh - you can joke - you can make snide remarks... But my plan would GUT any back door obama treachery that obama has in...

Judicial Watch has learned that the Obama administration is actively formulating plans to admit Ebola-infected non-U.S. citizens into the United States for treatment. Specifically, the goal of the administration is to bring Ebola patients into the United States for treatment within the first days of diagnosis. It is unclear who would bear the high costs of transporting and treating non-citizen Ebola patients. The plans include special waivers of laws and regulations that ban the admission of non-citizens with a communicable disease as dangerous as Ebola. One source tells us that the Obama administration is keeping this plan secret from Congress....

While the bipartisan voice grows to ban Ebola victims from entering the United States, a new report claims that President Obama is considering a plan to bring the world’s Ebola patients to the United States to be treated.

Mukpo became infected while working as a freelance cameraman for Vice News, NBC News and other media outlets in Liberia. Ashoka Mukpo tweeted from Nebraska Medical Center, where he is receiving care in the hospital's isolation unit. Mukpo is receiving an experimental Ebola drug called brincidofovir and IV fluids -- similar to the treatment Ebola patient Rick Sacra received during his three weeks at Nebraska Medical Center. Last week, Mukpo received a blood transfusion from Dr. Ken Brantly, the first American patient transferred to the U.S. for Ebola treatment. Sacra also got two blood transfusions from Brantly. Friends are turning...

Thomas Eric Duncan, the Liberian national who is fighting a severe Ebola infection in Dallas, is getting an experimental treatment, the hospital announced Monday. The drug is an investigational medication, brincidofovir, for Ebola Virus Disease. Chimerix, Inc., a biopharmaceutical company today announced that brincidofovir has been provided for potential use in patients with Ebola Virus Disease. ...

Dr. Gorbee Logan has given the drug, lamivudine, to 15 Ebola patients, and all but two survived. That's about a 13% mortality rate. Logan said he got the idea to try lamivudine when he read in scientific journals that HIV and Ebola replicate inside the body in much the same way. "Ebola is a brainchild of HIV," he said. "It's a destructive strain of HIV." At first he tried a drug called acyclovir, which is often given to HIV patients to treat infections that occur with their weakened immune systems. But it didn't seem to be effective. Then he tried...

Making Ebola medicine Zmapp takes time and the company has already distributed what it has. Government budget cuts may be partially to blame for the shortage.

Well before the Ebola virus was brought to the U.S. by a man traveling from Liberia, it was wreaking havoc in the West African country, where nearly 2,000 people have died during the worst Ebola outbreak in history. Now, some doctors in that country are trying new ways of treating Ebola-infected patients. Gorbee Logan, a doctor in rural Liberia, has given at least 15 Ebola patients lamivudine, which is considered a long-term and effective drug to treat HIV patients. All but two of them survived, Logan told CNN last week. Since that interview, Logan has been in contact with Anthony...

Ebola virus disease Fact sheet N°103Updated September 2014 Key facts Ebola virus disease (EVD), formerly known as Ebola haemorrhagic fever, is a severe, often fatal illness in humans. The virus is transmitted to people from wild animals and spreads in the human population through human-to-human transmission.The average EVD case fatality rate is around 50%. Case fatality rates have varied from 25% to 90% in past outbreaks.The first EVD outbreaks occurred in remote villages in Central Africa, near tropical rainforests, but the most recent outbreak in west Africa has involved major urban as well as rural areas.Community engagement is key to...

Nano-silver usage for Filovrii. Link only. http://whatreallyhappened.com/IMAGES/defense-threat-reduction-agency-silver-nanoparticles-neutralize-hemorrhagic-fever-viruses.pdf

A World Health Organization official says an Ebola vaccine developed in Canada may be the first to be approved for use, possibly before the year is out. Marie-Paule Kieny says data from the first safety studies in humans of two experimental vaccines should be available by November. She says if they are deemed safe to use, it could open the door initially for use in health-care workers tending the sick. One of the experimental vaccines was developed at Canada's National Microbiology Laboratory in Winnipeg. The company which licensed that vaccine, NewLink Genetics, announced this week that it had received approval...

A doctor is quarantined in East TN, waiting to see if he shows signs of #Ebola. @jmcneal talks to him via #Skype at 5 pic.twitter.com/L8uggRAbh0 Reply Retweet Favorite